MentionFox
Home › Executive changes › Precision Biosciences Inc
Leadership changes · SEC Form 8-K, Item 5.02

Precision Biosciences Inc executive changes

Every leadership change Precision Biosciences Inc reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Appointments named3
Latest filing2026-07-27

Precision Biosciences Inc filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-27. Between them they name 3 people. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-07-27 · 8-K

Appointed: Alex Kelly, Chief Operating Officer

As part of these leadership changes, the Board appointed Alex Kelly, age 60, as Chief Operating Officer of the Company.

Appointed: Naresh Tanna, Chief Financial Officer

Appointment of Chief Financial Officer In connection with Mr. Kelly's promotion to Chief Operating Officer, the Board appointed Naresh Tanna, age 45, as Chief Financial Officer of the Company.

Appointed: Mei Burris, Chief Accounting Officer

On the Effective Date, Mei Burris, age 40, the Company's Vice President of Finance, will be designated as and assume the responsibilities of principal accounting officer and Chief Accounting Officer.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Operating Officer at Precision Biosciences Inc, with the record behind each one.

Find candidates like Chief Operating Officer at Precision Biosciences Inc
Selling to Precision Biosciences Inc?

New leaders review vendors and budgets in their first months. Get an alert the next time Precision Biosciences Inc is in the news or changes leadership.

Get an alert when Precision Biosciences Inc changes leadership

Tools for this story

Each opens in a new tab, filled in for Precision Biosciences Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/precision-biosciences
Last updated 2026-09-27
Primary record: SEC filing
Precision Biosciences Inc (DTIL) executive changes: Alex Kelly appointed, Chief Operating Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/precision-biosciences